We propose a detailed study of the vitamin K dependend clotting factors. This study will encompass the Gla modification of the vitamin K substrates and their interactions with their activators, co-factors, substrates, and platelets. This project should lead to new and novel data about normal coagulation and the pathological abnormalities that lead to thrombosis and hemorrhage. In keeping with this broad thematic approach, we propose 4 interrelated projects led by principal investigators who have worked closely together for more than a decade. Project 1 addresses the vitamin K cycle, particularly the relationship of the carboxylase and the vitamin K dependent propeptides, and will attempt the isolation of the vitamin K epoxide reductase. Project 2 will investigate factor X's structure and function. The interactions of factor IX with platelets and endothelial cell surfaces, and how interactions of factor IX and other clotting factors with platelets regulate platelet procoagulant activity. Project 3 focuses on signal transduction events initiated by two major platelet collagen receptors, Alpha-2 Beta-1 and glycoprotein (GP)VI. The hypothesis that two small G-proteins, Rap1 and R-Ras, mediate cross-talk between these two collagen receptors will be tested and strategies to map collagen receptor-mediated signaling pathways, especially related to these small G-proteins, are outlined. Project 4 will develop three-dimensional structural models of complexes of vitamin K-dependent proteins and their inhibitors. This study will utilize the algorithms developed by the PI and his colleagues as well as recent advances in our knowledge of the partial x-ray crystal structures of several isolated components. These studies will make predictions that can be tested by the work proposed in Project 2.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Link, Rebecca P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Medicine
Chapel Hill
United States
Zip Code
Bode, Michael F; Mackman, Nigel (2016) A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice. Thromb Res 146:46-50
Boulaftali, Yacine; Owens 3rd, A Phillip; Beale, Ashley et al. (2016) CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice. Arterioscler Thromb Vasc Biol 36:792-9
Owens 3rd, A Phillip; Edwards, Todd L; Antoniak, Silvio et al. (2015) Platelet Inhibitors Reduce Rupture in a Mouse Model of Established Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol 35:2032-2041
Wu, Sangwook; Lee, Chang Jun; Pedersen, Lee G (2014) Analysis on long-range residue-residue communication using molecular dynamics. Proteins 82:2896-2901
Bode, Michael; Mackman, Nigel (2014) Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player. Vascul Pharmacol 62:57-62
Wu, Sangwook; Beard, William A; Pedersen, Lee G et al. (2014) Structural comparison of DNA polymerase architecture suggests a nucleotide gateway to the polymerase active site. Chem Rev 114:2759-74
Perera, Lalith; Beard, William A; Pedersen, Lee G et al. (2014) Applications of quantum mechanical/molecular mechanical methods to the chemical insertion step of DNA and RNA polymerization. Adv Protein Chem Struct Biol 97:83-113
Parker, Christine H; Morgan, Christopher R; Rand, Kasper D et al. (2014) A conformational investigation of propeptide binding to the integral membrane protein ?-glutamyl carboxylase using nanodisc hydrogen exchange mass spectrometry. Biochemistry 53:1511-20
Boulaftali, Yacine; Hess, Paul R; Getz, Todd M et al. (2013) Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest 123:908-16
Mutoh, Shingo; Sobhany, Mack; Moore, Rick et al. (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6:ra31

Showing the most recent 10 out of 57 publications